跳至主要内容
临床试验/NCT00678184
NCT00678184已完成4 期

The Effect of Acute HMG-CoA-Reductase Inhibition (Atorvastatin) on Renal Sodium Excretion, Renal Hemodynamics, Tubular Function and Vasoactive Hormones in Healthy Subjects During Normal and High Sodium Intake

Regional Hospital Holstebro4 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2007年1月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
23
试验地点
4
主要终点
Glomerular filtration rate, clearance of sodium and lithium, fractional excretion of sodium and lithium, U-AQP-2, total sodium excretion, free water clearance

研究概览

简要总结

We wanted to test the hypothesis that acute treatment with atorvastatin changes renal sodium handling, renal hemodynamics, tubular function and vasoactive hormones in healthy humans during normal and high sodium intake.

详细描述

We wanted to test the hypothesis that acute treatment with atorvastatin changes renal sodium handling, renal hemodynamics, tubular function and vasoactive hormones in healthy humans during normal and high sodium intake.

We wanted to analyze if changes in renal hemodynamics, tubular function, hormones, blood pressure and HR under acute treatment with atorvastatin depends on sodium intake.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age 20-50 yr
  • Females had to use oral contraceptive treatment or IUD.

排除标准

  • Clinical signs or history of disease of the heart, lungs, kidneys, liver, brain or endocrine organs
  • Abnormal laboratory blood tests (hemoglobin, sodium, potassium, albumin, creatinine, blood glucose, bilirubin, alanin amino transferase, alkalic phosphatase)
  • Albuminuria or glucosuria
  • arterial hypertension
  • alcohol abuse
  • medical treatment, except contraceptives
  • pregnancy or breast feeding
  • blood donation one month before the study.

结局指标

主要结局

Glomerular filtration rate, clearance of sodium and lithium, fractional excretion of sodium and lithium, U-AQP-2, total sodium excretion, free water clearance

时间窗: 6 months

次要结局

  • AVP, Ang-II, Aldosterone, ANP, BNP, PRC, BP and HR.(6 months)

研究者

发起方
Regional Hospital Holstebro
申办方类型
Other

研究点 (4)

Loading locations...

相似试验